Preliminary validation of a web-based MRI scoring system for children with chronic nonbacterial osteomyelitis

Farzana Nuruzzaman1, T Shawn Sato2, Jennifer Stimec3

  • 1Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA. Farzana.nuruzzaman@stonybrookmedicine.edu.

Abstract

Insights

A new web-based system for scoring chronic nonbacterial osteomyelitis (CNO) using MRI is usable and reliable. This refined CROMRIS tool shows good agreement among radiologists for assessing CNO lesions.

Area of Science:

  • Radiology
  • Medical Imaging
  • Rheumatology

Background:

  • The original ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) tool was labor-intensive.
  • Chronic nonbacterial osteomyelitis (CNO) requires accurate assessment of bone and soft tissue inflammation via MRI.
  • A need existed for a more efficient and reliable CNO scoring method.

Purpose of the Study:

  • To refine and adapt the paper-based CROMRIS tool into a web-based system.
  • To evaluate the usability of the web-based CROMRIS system among radiologists.
  • To assess the agreement and interrater reliability of the CROMRIS scores across different body sites.

Main Methods:

  • A user-centered design approach was employed, involving software developers, rheumatologists, and radiologists.
  • A web-based prototype was developed and iteratively refined.
  • Radiologists scored bone marrow hyperintensity, soft tissue/periosteal changes, bony expansion, and lesion size using the CROMRIS system. Interrater reliability was assessed using kappa statistics and intraclass correlation coefficients.

Main Results:

  • System usability scores improved from below average (64.5) to above average (75) after user feedback.
  • Excellent interrater reliability (ICC > 0.9) was observed for the CROMRIS Activity Index in the clavicle, tibia, and spines.
  • Substantial interrater reliability (kappa > 0.6) was demonstrated among radiologists for key CNO-affected bone sites.

Conclusions:

  • The developed web-based CROMRIS portal is usable and demonstrates substantial-to-moderate agreement among experienced radiologists.
  • The tool shows good reliability for assessing CNO activity across various body regions.
  • The refined CROMRIS system has potential for use in future clinical trials after calibration.

Related Concept Videos

Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
222
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.0K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119